Management of Drug-Resistant Epilepsy

ABSTRACTPurpose of Review: This review discusses the definition, evaluation, and management of patients with drug-resistant epilepsy.Recent Findings: Drug-resistant epilepsy is defined as a failure of two or more appropriately selected and adequately tried anticonvulsant medications to achieve seizure freedom for a sustained period of time in either monotherapy or polytherapy. Once this definition has been met, the likelihood that further medication trials will lead to seizure freedom is in the range of 5% to 10%. Reasons for pseudoresistance to anticonvulsant therapy include wrong diagnosis, wrong drug, wrong dose, or poor compliance. Patients with epilepsy who are drug resistant should be referred to an epilepsy center for a surgical evaluation or more specialized care. The odds of being seizure free following epilepsy surgery versus continued medications are around 4 to 3. Currently, surgical referrals occur late in the disease.Summary: Determination of drug-resistant epilepsy and referral to an epilepsy surgical center can be expedited to avoid exposing patients to continued seizures and the resultant morbidity.

[1]  L. Hirsch,et al.  Diagnostic Utility of an Epilepsy Monitoring Unit , 2007, American journal of medical quality : the official journal of the American College of Medical Quality.

[2]  E. Chang,et al.  Vagus nerve stimulation for epilepsy : a meta analysis of efficacy and predictors of response A review , 2011 .

[3]  Edward F. Chang,et al.  Rates and predictors of seizure freedom in resective epilepsy surgery: an update , 2014, Neurosurgical Review.

[4]  G. Baker,et al.  Quality-of-life trajectories in epilepsy: A review of the literature , 2008, Epilepsy & Behavior.

[5]  P. Cooper,et al.  Ketogenic diet and other dietary treatments for epilepsy. , 2016, The Cochrane database of systematic reviews.

[6]  W. Hauser,et al.  Likelihood of seizure remission in an adult population with refractory epilepsy , 2007, Annals of neurology.

[7]  G. Cascino,et al.  Resective epilepsy surgery for drug-resistant focal epilepsy: a review. , 2015, JAMA.

[8]  S. Shorvon.  The Epidemiology and Treatment of Chronic and Refractory Epilepsy , 1996, Epilepsia.

[9]  M. Brodie,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2011 .

[10]  W. LaFrance,et al.  Differentiating frontal lobe epilepsy from psychogenic nonepileptic seizures. , 2011, Neurologic clinics.

[11]  G. Worrell,et al.  Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: Final results of the RNS System Pivotal trial , 2014, Epilepsia.

[12]  Y. Schiller,et al.  Quantifying the response to antiepileptic drugs , 2008, Neurology.

[13]  E. Perucca,et al.  Determinants of health‐related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments , 2011, Epilepsia.

[14]  J. Cross,et al.  The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial , 2008, The Lancet Neurology.

[15]  B. Vickrey,et al.  Cannabinoids for epilepsy. , 2014, The Cochrane database of systematic reviews.

[16]  Laura J. Bonnett,et al.  Treatment outcome after failure of a first antiepileptic drug , 2014, Neurology.

[17]  Jean-Pierre Daurès,et al.  The prevalence of epilepsy and pharmacoresistant epilepsy in adults: A population‐based study in a Western European country , 2008, Epilepsia.

[18]  Benjamin J. Whalley,et al.  Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders , 2014, Epilepsia.

[19]  E. Kossoff,et al.  A Modified Atkins Diet Is Effective for the Treatment of Intractable Pediatric Epilepsy , 2006, Epilepsia.

[20]  Steve S. Chung,et al.  Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy , 2010, Epilepsia.

[21]  Hermann Engesser.  Next Level , 2016, Informatik-Spektrum.

[22]  A. Ylinen,et al.  The benefit of active drug trials is dependent on aetiology in refractory focal epilepsy , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[23]  W T Blume,et al.  A randomized, controlled trial of surgery for temporal-lobe epilepsy. , 2001, The New England journal of medicine.

[24]  I. Najm,et al.  Improved outcomes with earlier surgery for intractable frontal lobe epilepsy , 2013, Annals of neurology.

[25]  S. Shorvon,et al.  Results of treatment changes in patients with apparently drug‐resistant chronic epilepsy , 2007, Annals of neurology.

[26]  E. Thiele,et al.  Low-glycemic-index treatment: A liberalized ketogenic diet for treatment of intractable epilepsy , 2005, Neurology.

[27]  A. Berg,et al.  Remission of epilepsy after two drug failures in children: A prospective study , 2009, Annals of neurology.

[28]  P. Kwan,et al.  Drug-resistant epilepsy. , 2011, The New England journal of medicine.

[29]  W. Hauser.  The natural history of drug resistant epilepsy: epidemiologic considerations. , 1992, Epilepsy research. Supplement.

[30]  W. Sutherling,et al.  Quality of Life of Epilepsy Surgery Patients as Compared with Outpatients with Hypertension, Diabetes, Heart Disease, and/or Depressive Symptoms , 1994, Epilepsia.

[31]  Rm. Wilder,et al.  The effects of ketonemia on the course of epilepsy , 1921 .

[32]  I. Fried,et al.  Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. , 2012, JAMA.

[33]  P. Kwan,et al.  Early identification of refractory epilepsy. , 2000, The New England journal of medicine.

[34]  S. Roper,et al.  Disrupting abnormal electrical activity with deep brain stimulation: is epilepsy the next frontier? , 2010, Neurosurgical focus.

[35]  Anil Nanda,et al.  Vagal nerve stimulation for the treatment of medically refractory epilepsy: a review of the current literature. , 2012, Neurosurgical focus.

[36]  Dieter Schmidt,et al.  Long‐term seizure outcome of surgery versus no surgery for drug‐resistant partial epilepsy: A review of controlled studies , 2009, Epilepsia.

[37]  W. LaFrance,et al.  Diagnosis and Treatment of Nonepileptic Seizures , 2016, Continuum.

[38]  F. Vale,et al.  The health care burden of patients with epilepsy in the United States: an analysis of a nationwide database over 15 years. , 2012, Neurosurgical focus.

[39]  P. House.  Responsive cortical stimulation for the treatment of medically intractable partial epilepsy , 2012 .

[40]  Epilepsy surgery: an evidence summary. , 2012, Ontario health technology assessment series.

[41]  Robert A Gross,et al.  Levels of evidence , 2008, Neurology.

[42]  L. Morrison,et al.  Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group , 2009, Epilepsia.

[43]  Lippincott Williams Wilkins,et al.  Practice Parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003, Neurology.

[44]  D. Spencer,et al.  Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003, Neurology.

[45]  N. Barbaro,et al.  Epilepsy surgery trends in the United States, 1990–2008 , 2012, Neurology.